Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From I-Hub (Neverending)

Ba,

I would agree as far as long term real value goes. As far as short term shareprice appreciation you only have to look at the last bump to realize a 100 to 150 percent gain and that was based on nothing but the re-exam process and NIRC. Yes it is only window dressing as compared to the larger issues, but it does present a good opportunity.

Good Luck

(I) C. W.

Share
New Message
Please login to post a reply